Summary:
«Digital biomarkers are important for the quality and safety of patient care, but they are just one piece of the puzzle. They can also be used to improve the quality and efficiency of clinical trials by enabling researchers to gather more data on a variety of variables.»
«This requires some effort and planning in order to achieve this goal. One approach is to use digital biomarkers as a starting point in testing alternative treatments or interventions that may have positive effects on patients’ symptoms. Digital biomarkers can also be used to help with cost-effectiveness analyses, which is a critical part of clinical trials because it allows researchers to estimate how much it would cost to perform trials in different settings.»
«Once you have your digital biomarker, you need a research study that will allow you to collect data from various groups (patients, clinicians, etc.). A large number of small studies done by different groups on different populations can help determine how well digital biomarkers work for your product/service.»
«Digital biomarkers are a set of commonly used measurements (e.g. blood glucose, blood pressure) that can be used to monitor the physiological activity of the body and can even be used to detect diseases and conditions associated with the body (e.g. diabetes). Digital health wearables, on the other hand, consist of wearable devices that constantly collect data related to the user’s health status, as well as allow for a more personalized approach to management and treatment (e.g. a heart rate monitor).The potential benefits for medical professionals include improved patient care and communication with patients, as well as increased accuracy in diagnosis of diseases and conditions associated with the body (e.g. diabetes).»
Article written by Joao Bocas.
04|04|2022
Source:
Digital Salutem
https://digitalsalutem.com/digital-biomarkers-wearables-clinical-trials/